0001828185-24-000056.txt : 20240514
0001828185-24-000056.hdr.sgml : 20240514
20240514162116
ACCESSION NUMBER: 0001828185-24-000056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240510
FILED AS OF DATE: 20240514
DATE AS OF CHANGE: 20240514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scheeren Joseph
CENTRAL INDEX KEY: 0001852070
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40367
FILM NUMBER: 24944696
MAIL ADDRESS:
STREET 1: THE SCHRODINGER BUILDING
STREET 2: HEATLEY ROAD, THE OXFORD SCIENCE PARK
CITY: OXFORD
STATE: X0
ZIP: OX4 4GE
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Barinthus Biotherapeutics plc.
CENTRAL INDEX KEY: 0001828185
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: UNIT 6-10, ZEUS BUILDING
STREET 2: RUTHERFORD AVENUE, HARWELL
CITY: DIDCOT
STATE: X0
ZIP: OX11 0DF
BUSINESS PHONE: 44 (0) 1865 818808
MAIL ADDRESS:
STREET 1: UNIT 6-10, ZEUS BUILDING
STREET 2: RUTHERFORD AVENUE, HARWELL
CITY: DIDCOT
STATE: X0
ZIP: OX11 0DF
FORMER COMPANY:
FORMER CONFORMED NAME: Vaccitech plc
DATE OF NAME CHANGE: 20210407
FORMER COMPANY:
FORMER CONFORMED NAME: Vaccitech Ltd
DATE OF NAME CHANGE: 20201014
4
1
wk-form4_1715718060.xml
FORM 4
X0508
4
2024-05-10
0
0001828185
Barinthus Biotherapeutics plc.
BRNS
0001852070
Scheeren Joseph
UNIT 6-10, ZEUS BUILDING
RUTHERFORD AVENUE, HARWELL
DIDCOT
X0
OX11 0DF
UNITED KINGDOM
1
0
0
0
0
Share Option (Right to Buy)
2.34
2024-05-10
4
A
0
19516
0
A
2034-05-10
Ordinary Shares
19516
19516
D
The shares underlying this option shall vest in full on the earlier of (i) May 10, 2025 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
/s/ William Enright, Attorney-in-Fact
2024-05-14